Surgical Science Sweden AB Stock Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
04-15 | Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB | CI |
03-12 | Surgical Science Sweden to Step Down; Search for Successor Starts | MT |
Sales 2024 * | 999M 92.31M 126M | Sales 2025 * | 1.2B 111M 151M | Capitalization | 7.58B 700M 957M |
---|---|---|---|---|---|
Net income 2024 * | 212M 19.58M 26.78M | Net income 2025 * | 304M 28.08M 38.41M | EV / Sales 2024 * | 6.72 x |
Net cash position 2024 * | 863M 79.68M 109M | Net cash position 2025 * | 1.13B 105M 143M | EV / Sales 2025 * | 5.38 x |
P/E ratio 2024 * |
35.6
x | P/E ratio 2025 * |
24.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.33% |
Latest transcript on Surgical Science Sweden AB
Managers | Title | Age | Since |
---|---|---|---|
Anders Larsson
FOU | Founder | 51 | 97-07-23 |
Gisli Hennermark
CEO | Chief Executive Officer | 52 | 14-12-31 |
Director of Finance/CFO | 54 | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roland Bengtsson
CHM | Chairman | 69 | 04-12-31 |
Director/Board Member | 57 | 16-12-31 | |
Director/Board Member | 49 | 21-05-11 |
1st Jan change | Capi. | |
---|---|---|
+5.52% | 32.83B | |
+17.58% | 7.73B | |
+23.16% | 3.96B | |
-17.53% | 3.12B | |
-20.33% | 1.38B | |
-30.65% | 1.2B | |
+7.73% | 963M | |
-33.44% | 934M | |
-26.60% | 829M |